U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07052903) titled 'TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy' on June 30.
Brief Summary: The purpose of this study is to:
* Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events
* Evaluate the efficacy of nucresiran compared to placebo on additional assessments of CV events and/or death
* Evaluate the efficacy of nucresiran compared to placebo on patient-reported health status and health-related quality of life
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Transthyretin Amyloidosis With Cardiomyopathy...